A Glasgow-based SportTech has raised £1.2m and teamed up with two-time major winner and golf’s world number three Xander Schauffele.
Theo Health is set to continue the development of its clothing platform designed to help elite athletes and their strength and conditioning coaches with lab-grade data in real time.
Schauffele, an Olympic gold medallist, has joined the startup as both an investor and one of the founding ‘Alpha Athletes’ in its elite testing programme that aims to support athletes around injury prevention and recovery.
The company’s CEO and founder, Jodie Sinclair, had been scouted for a US soccer scholarship before rupturing her ACL the week before starting university, which ended her competitive sporting career.
“There was no feedback during my recovery – I had no way of knowing if I was doing the right thing, or making it worse,” she explained.
“Theo is the system I wish I had when I was injured, one that makes recovery measurable, progress visible, and elite performance possible again.
“After a couple of years in stealth mode where we deliberately stayed under the radar, focusing on IP protection, product development, and building a world-class team, it’s great to now be back in the spotlight.”
The ‘Theo Alpha Shorts’ – the firm’s first product – embed inertial measurement units within high-performance compression wear to track every rep in real time.
Fusing advanced biomechanics with wearable tech, it turns every rep into actionable feedback – with post-session reports to match.
David Sundberg, personal trainer to Schauffele, added: “It all makes sense – I didn’t expect it to be this easy to understand.
“These components help with form, others with strength, and others with speed. It’s simple for the athlete, but there’s so much information underneath.”
Theo Health is also looking to tackle the gender data gap in sports. Female athletes are up to eight times more likely to suffer ACL injuries, yet less than 5% of injury studies focus on women.
Sinclair noted that it is ‘the first smart-clothing system truly built with female physiology in mind, without compromising on performance’.
The company is on the countdown to its Alpha launch – an intensive testing phase with a hand-selected group of world-class athletes and their coaches – and preparing for Beta pilots with one of the world’s top European football clubs.
After testing with elite athletes and teams, a mass market launch is expected by the summer of 2027.